UK markets closed

Evgen Pharma plc (EVG.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
13.38+1.00 (+8.08%)
At close: 5:07PM BST
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/03/2020
31/03/2019
31/03/2018
31/03/2017
Total revenue
0
0
0
-
-
Operating expenses
Research development
1,699
1,699
1,689
-
-
Selling general and administrative
565
565
499
-
-
Total operating expenses
3,146
3,146
3,120
3,026
3,658
Operating income or loss
-3,146
-3,146
-3,120
-3,026
-3,658
Interest expense
-
-
-
0
3
Income before tax
-3,166
-3,166
-3,120
-3,026
-3,644
Income tax expense
-451
-451
-496
-443
-576
Income from continuing operations
-2,715
-2,715
-2,624
-2,583
-3,068
Net income
-2,715
-2,715
-2,624
-2,583
-3,068
Net income available to common shareholders
-2,715
-2,715
-2,624
-2,583
-3,068
Basic EPS
-
-
-0.03
-0.03
-0.04
Diluted EPS
-
-
-0.03
-0.03
-0.04
Basic average shares
-
-
95,857
78,697
73,153
Diluted average shares
-
-
95,857
78,697
73,153
EBITDA
-
-3,125
-3,099
-3,005
-3,624